viewZoetic International PLC

Zoetic's Nick Tulloch discusses new products, OTC listing and ambitious growth plans

Zoetic International's (LON:ZOE) Nick Tulloch sat down with Proactive London's Andrew Scott for an extended discussion on the firm's performance to date since its refocus on the CBD market and what's planned in the coming weeks and months.

''The really exciting part is that we're moving into cosmetics, at the end of November we should have a line of four cosmetics - a hand cream, a night cream, a facial serum and a lip balm - all high quality products in line with the rest of the brand with CBD included''.

Tulloch also discusses the recently announced share option scheme for its staff as well as what's happening with their OTC listing.

Quick facts: Zoetic International PLC

Price: 4.9 GBX

Market: LSE
Market Cap: £8.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zoetic International PLC named herein, including the promotion by the Company of Zoetic International PLC in any Content on the Site, the...



Zoetic reports 'ongoing enthusiasm for its products' despite market challenges

Zoetic International's (LON:ZOE) Nick Tulloch tells Proactive London's Andrew Scott they're taking prudent actions to manage the challenges brought on by the outbreak of coronavirus.  He adds that despite the volatility their distribution partners remain very supportive.

1 week, 5 days ago

2 min read